GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intra-Cellular Therapies Inc (STU:23I) » Definitions » Float Percentage Of Total Shares Outstanding

Intra-Cellular Therapies (STU:23I) Float Percentage Of Total Shares Outstanding : 87.13% (As of Jun. 02, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Intra-Cellular Therapies Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Intra-Cellular Therapies's float shares is 91.99 Mil. Intra-Cellular Therapies's total shares outstanding is 105.57 Mil. Intra-Cellular Therapies's float percentage of total shares outstanding is 87.13%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Intra-Cellular Therapies's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Intra-Cellular Therapies's Institutional Ownership is 65.10%.

Intra-Cellular Therapies Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Intra-Cellular Therapies's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=91.99/105.57
=87.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intra-Cellular Therapies (STU:23I) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intra-Cellular Therapies Inc (STU:23I) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
ELAN LNTH ALKS PRGO PBH ALVO AMPH DVAX CTLT IRWD ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ITCI:USA ITCI:Mexico 23I:Germany
Address
430 East 29th Street, New York, NY, USA, 10016
Website
https://www.intracellulartherapies.com
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Intra-Cellular Therapies (STU:23I) Headlines

No Headlines